Christopher Peetz - 10 May 2021 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
President and CEO, Director
Signature
/s/ Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
10 May 2021
Net transactions value
+$21,243
Form type
4
Filing time
12 May 2021, 17:41:08 UTC
Next filing
27 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common STock Award $21,243 +1,453 +106% $14.62 2,824 10 May 2021 Direct F1
holding MIRM Common Stock 201,570 10 May 2021 By The Peetz Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 1,453 shares by the Reporting Person on May 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan.